This virtual conference aims at connecting topics and scientists across the pharma, biotech, venture capital, and CRO industries to discuss the recent promises and challenges of the new pharma ecosystem.
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
Leibniz-Institut für Molekulare Pharmakologie (FMP) and the Humboldt Universität zu Berlin (HU Berlin)
New York University
The NUVISAN group is a Contract Research Organization (CRO) and Contract Manufacturing Organization (CDMO) with its headquarters in Neu-Ulm and six sites in Germany and France (Neu-Ulm, Berlin, Grafing, Gauting, Waltrop and Sophia-Antipolis) in addition to monitoring activities with offices in Argentina, Peru and Brazil as well as in the USA.
NUVISAN offers integrated and coupled services and solutions along the drug development value chain from target identification to the patient with all supporting services (DMPK, GMP synthesis, formulation development and analysis, bioanalysis, Phase 1 CPU, clinical trial supplies and monitoring).
NUVISAN Pharma Holding GmbH
Elmar Rothenfusser | +49 731 9840 143 | email@example.com
Valeria Vasiliev | +49 731 9840 481 | firstname.lastname@example.org
Wegenerstr. 13 | 89231 Neu-Ulm | Germany